Long-Term Kidney Transplant Outcomes Linked to 30% eGFR Decline
An eGFR decline of at least 30% during the 6 to 24 months after kidney transplantation predicts a higher risk of graft loss.
An eGFR decline of at least 30% during the 6 to 24 months after kidney transplantation predicts a higher risk of graft loss.
In a study, viral infections occurred in 52.4% of patients with a BMI of 35 kg/m2 or higher compared with 37.1% of those with a lower BMI.
Mortality no different for early versus delayed strategy for patients with severe acute kidney injury.
The higher the baseline PSA levels, the greater the risk of being diagnosed with any or significant prostate cancer.
In particular, no hepatic toxicities emerged during a 52-week phase 3 trial.
In a study, use of the medication was associated with a significant 61% decreased risk.
Significant improvements in lower urinary tract symptoms are durable to 24 months, data show.